Clinical Trials on Advanced Melanoma in United Kingdom
Total 4590 results
-
Bristol-Myers SquibbCompletedAdvanced MelanomaUnited States, United Kingdom
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); National Comprehensive Cancer NetworkTerminatedRecurrent Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Stage IIB Melanoma (Locally Advanced) | Stage IIC Melanoma (Locally Advanced) | Stage IV Melanoma (Limited, Resectable)United States
-
MorphotekTerminatedMelanoma | Metastatic Melanoma | Advanced Melanoma | Malignant Metastatic MelanomaUnited States
-
Yana NajjarBristol-Myers Squibb; PfizerActive, not recruitingUnresectable Melanoma | Advanced MelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis PharmaceuticalsActive, not recruitingMelanoma | Unresectable Melanoma | Advanced MelanomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Metastatic Melanoma | Advanced Non-hematologic MalignanciesUnited States
-
Agenus Inc.SuspendedAdvanced MelanomaUnited States, Spain, United Kingdom, France, Germany, Switzerland, Belgium, Italy, Brazil, Russian Federation
-
University of Colorado, DenverMerck Sharp & Dohme LLCActive, not recruitingStage IV Melanoma | Advanced Melanoma | Stage III MelanomaUnited States
-
Oxford University Hospitals NHS TrustUniversity of Oxford; Barts & The London NHS Trust; Ninewells HospitalCompletedMelanoma Stage III | Melanoma, Stage II | Melanoma, Stage IUnited Kingdom
-
Regeneron PharmaceuticalsBristol-Myers SquibbActive, not recruitingMelanoma | Metastatic Melanoma | Unresectable Melanoma | Advanced MelanomaUnited States
-
Regeneron PharmaceuticalsBristol-Myers SquibbCompletedMelanoma | Metastatic Melanoma | Unresectable Melanoma | Advanced MelanomaUnited States
-
Elizabeth DavisBristol-Myers SquibbTerminatedMetastatic Melanoma | Advanced Melanoma | Metastatic Melanoma Stratified by MHC-II ExpressionUnited States
-
University of California, San FranciscoMerck Sharp & Dohme LLCRecruitingMelanoma | Advanced MelanomaUnited States
-
Mannkind CorporationCompletedAdvanced Melanoma | Stage III and IV MelanomaUnited States
-
Yana NajjarMerck Sharp & Dohme LLCRecruitingAdvanced MelanomaUnited States
-
Abramson Cancer Center at Penn MedicineNovartis PharmaceuticalsTerminated
-
M.D. Anderson Cancer CenterGenta IncorporatedCompleted
-
The Christie NHS Foundation TrustUniversity of Liverpool; University of Manchester; Manchester Academic Health...TerminatedMelanoma (Skin) | Melanoma, Stage IIUnited Kingdom
-
RAPT Therapeutics, Inc.Terminated
-
Yousef ZakhariaUniversity of Iowa; ExelixisRecruitingAdvanced Metastatic MelanomaUnited States
-
Immodulon Therapeutics LtdTerminatedMalignant MelanomaUnited Kingdom
-
Bristol-Myers SquibbMedarexCompleted
-
Leeds Cancer Centre at St. James's University HospitalUnknownMelanoma (Skin) | Hereditary Multiple MelanomaUnited Kingdom
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustCompletedA Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread (NICAM)Mucosal Lentiginous Melanoma | Acral Lentiginous Malignant MelanomaUnited Kingdom
-
Lytix Biopharma ASLaboratory Corporation of America; OWLActive, not recruitingAdvanced MelanomaUnited States, Spain, France, Norway
-
Royal Marsden NHS Foundation TrustUnknown
-
Bristol-Myers SquibbMedarexCompletedAdvanced MelanomaUnited States
-
The Christie NHS Foundation TrustNational Institute for Health Research, United KingdomTerminatedMetastatic MelanomaUnited Kingdom
-
Scancell LtdRecruitingMelanoma (Skin) | Malignant Melanoma | Melanoma Stage IV | Melanoma Stage IIIUnited Kingdom
-
Bristol-Myers SquibbCompletedAdvanced or Metastatic MelanomaUnited States
-
Merck Sharp & Dohme LLCTerminatedAdvanced MelanomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedAdvanced BRAF Mutant MelanomaUnited States
-
The Clatterbridge Cancer Centre NHS Foundation...Pfizer; Cancer Research UKCompletedMetastatic Uveal MelanomaUnited Kingdom
-
Bristol-Myers SquibbCompletedAdvanced Cutaneous MelanomaGermany, Poland, Spain, Australia, France, Argentina, Ireland, Israel, Belgium, United States, Switzerland, United Kingdom, Greece, Austria, Canada
-
Piramal Enterprises LimitedMelanoma Research Foundation Breakthrough ConsortiumSuspendedAdvanced or Inoperable Malignant Melanoma With BRAF MutationUnited States
-
Oxford University Hospitals NHS TrustUniversity of SouthamptonRecruiting
-
Mount Vernon Cancer Centre at Mount Vernon HospitalUnknownMelanoma (Skin)United Kingdom
-
Royal Marsden NHS Foundation TrustCompletedMelanoma and SarcomaUnited Kingdom
-
Hoffmann-La RocheTerminatedAdvanced BRAFV600 Wild-type MelanomaUnited States, Korea, Republic of, Australia, Belgium, France, Russian Federation, Italy, Netherlands, Spain, United Kingdom, Brazil, Poland, Germany, Greece, Hungary
-
Ryan StephensonRecruiting
-
Leeds Cancer Centre at St. James's University HospitalUnknown
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingMelanoma | Advanced Melanoma | Melanoma Stage IV | Melanoma Stage IIIUnited States
-
Leeds Cancer Centre at St. James's University HospitalUnknownMelanoma (Skin)United Kingdom
-
Instil BioTerminatedAdvanced Cutaneous MelanomaUnited States, Canada, United Kingdom
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedMelanoma NeoplasmsUnited States, United Kingdom
-
Leeds Cancer Centre at St. James's University HospitalUnknown
-
Immunocore LtdTerminated
-
PfizerPierre Fabre LaboratoriesActive, not recruitingAdvanced Solid Tumors | Metastatic MelanomaUnited States, Spain, Belgium, Canada, Netherlands
-
Cambridge University Hospitals NHS Foundation TrustCompletedMelanoma (Skin)United Kingdom